Cargando…
Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients
Background: We aimed to investigate the effect of non-alcoholic fatty liver disease (NAFLD) on BNT162b2 immunogenicity against wild-type SARS-CoV-2 and variants and infection outcome, as data are lacking. Methods: Recipients of two doses of BNT162b2 were prospectively recruited. Outcomes of interest...
Autores principales: | Cheung, Ka Shing, Lam, Lok Ka, Mao, Xianhua, Tan, Jing Tong, Ooi, Poh Hwa, Zhang, Ruiqi, Chan, Kwok Hung, Hung, Ivan F. N., Seto, Wai Kay, Yuen, Man Fung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054100/ https://www.ncbi.nlm.nih.gov/pubmed/36992081 http://dx.doi.org/10.3390/vaccines11030497 |
Ejemplares similares
-
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
por: Cheung, Ka Shing, et al.
Publicado: (2022) -
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
por: Cheung, Ka Shing, et al.
Publicado: (2022) -
Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 Vaccination
por: Cheung, Ka-Shing, et al.
Publicado: (2022) -
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Cheung, Ka Shing, et al.
Publicado: (2023) -
Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)